Palisade Bio
PALI
1 hedge funds and large institutions have $10.8M invested in Palisade Bio in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
93% more capital invested
Capital invested by funds: $5.63M → $10.8M (+$5.21M)
0% more funds holding
Funds holding: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Commonwealth Equity Services
Waltham,
Massachusetts
| $27K | – | – | – |
|
|
GIA
27
GHP Investment Advisors
Denver,
Colorado
| $27K | – | – | – |
|
28
Wells Fargo
San Francisco,
California
| $27K | – | – | – |
|
|
OIA
29
Optimum Investment Advisors
Chicago,
Illinois
| $5K | – | – | – |
|
30
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $5K | – | – | – |
|
31
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | – | – | – |
|
32
Creative Planning
Overland Park,
Kansas
| $3K | – | – | – |
|
33
AllianceBernstein
Nashville,
Tennessee
| $1K | – | – | – |
|
34
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $9 | – | – | – |
|
PALI Hedge Fund Activity: Q3 2013 in Review
1 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q3 2013, worth a combined $10.8M — up 93% from $5.63M a quarter earlier.
Fund positioning in PALI was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 1 institutional investor held Palisade Bio (PALI) as of Q3 2013, unchanged from Q2 2013.
- Funds reported $10.8M of Palisade Bio stock for Q3 2013, up 93% quarter-over-quarter.
- 0 funds opened new Palisade Bio positions in Q3 2013 and 0 closed out.
Based on aggregated 13F filings for Q3 2013.